Citation: A. Cleton et al., ADAPTIVE-CHANGES IN THE PHARMACODYNAMICS OF MIDAZOLAM IN DIFFERENT EXPERIMENTAL-MODELS OF EPILEPSY - KINDLING, CORTICAL STIMULATION AND GENETIC ABSENCE EPILEPSY, British Journal of Pharmacology, 125(4), 1998, pp. 615-620
Authors:
CLETON A
EDELBROEK PM
VOSKUYL RA
DANHOF M
Citation: A. Cleton et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF THE EEG EFFECT OF THE GABA UPTAKE INHIBITORS R-TIAGABINE AND S-TIAGABINE IN RATS, British Journal of Pharmacology, 123, 1998, pp. 22-22
Authors:
MATHOT RAA
CLETON A
SOUDIJN W
IJZERMAN AP
DANHOF M
Citation: Raa. Mathot et al., PHARMACOKINETIC MODELING OF THE HEMODYNAMIC-EFFECTS OF THE A(2A) ADENOSINE RECEPTOR AGONIST CGS 21680C IN CONSCIOUS NORMOTENSIVE RATS, British Journal of Pharmacology, 114(4), 1995, pp. 761-768
Authors:
IRTH H
CLETON A
MATHOT RAA
DANHOF M
IJZERMAN AP
TJADEN UR
VANDERGREEF J
Citation: H. Irth et al., LIQUID-CHROMATOGRAPHIC DETERMINATION OF THE ADENOSINE RECEPTOR AGONIST CGS-21680 IN BLOOD USING ONLINE SOLID-PHASE EXTRACTION ON A PHENYLBORONIC ACID SUPPORT AND FLUORESCENCE DETECTION, Journal of chromatography B. Biomedical applications, 658(1), 1994, pp. 207-212